Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema.
about
Anti-vascular endothelial growth factor for diabetic macular oedemaAntiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedemaAntiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedemaRole of implants in the treatment of diabetic macular edema: focus on the dexamethasone intravitreal implantClinical development of new treatments for diabetic macular oedemaNew approaches for the treatment of diabetic macular oedema: recommendations by an expert panelLaser, intravitreal drug application, and surgery to treat diabetic eye diseaseA review of therapies for diabetic macular oedema and rationale for combination therapyRecent developments in laser treatment of diabetic retinopathyProtocol: Effect of intravitreal bevacizumab (avastin) in the treatment of macular edema: A systematic review of randomized controlled trialsVascular Endothelial Growth Factor Inhibitors for Diabetic Retinopathy.Diabetic macular edema: New promising therapies.Ocular problems in the patient with end-stage renal disease.Intravitreal bevacizumab vs intravitreal triamcinolone combined with macular laser grid for diffuse diabetic macular oedema.New Therapeutic Approaches in Diabetic Retinopathy.Cost-effectiveness of treatment of diabetic macular edema.Systematic review of intravitreal bevacizumab injection for treatment of primary diabetic macular oedema.Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study12-month results of the standardised combination therapy for diabetic macular oedema: intravitreal bevacizumab and navigated retinal photocoagulationEfficacy of intravitreal anti-vascular endothelial growth factor or steroid injection in diabetic macular edema according to fluid turbidity in optical coherence tomography.Diabetic macular edema: new trends in management.Visual and anatomical outcomes following vitrectomy for complications of diabetic retinopathy: the DRIVE UK studyDiabetic macular edema: therapeutic options.Pain and accuracy of focal laser treatment for diabetic macular edema using a retinal navigated laser (Navilas).Combination therapy for diabetic macular edema.[Navigated focal retinal laser therapy using the NAVILASĀ® system for diabetic macula edema].Use of bevacizumab for macular edema secondary to branch retinal vein occlusion: a systematic review.Corticosteroid use for diabetic macular edema: old fad or new trend?The relative clinical effectiveness of ranibizumab and bevacizumab in diabetic macular oedema: an indirect comparison in a systematic review.Evidence for anti-VEGF treatment of diabetic macular edema.Using skew-symmetric mixed models for investigating the effect of different diabetic macular edema treatments by analyzing central macular thickness and visual acuity responsesPathophysiology and treatment of diabetic retinopathy.Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.Association of systemic comorbidity in diabetic serous macular detachment and comparison of various combination therapies in its management.Current treatments in diabetic macular oedema: systematic review and meta-analysisBevacizumab for the management of diabetic macular edemaRanibizumab: the first vascular endothelial growth factor inhibitor approved for the treatment of diabetic macular edema.Vitrectomy combined with intravitreal triamcinolone acetonide injection and macular laser photocoagulation for nontractional diabetic macular edema.[Navigated retinal laser therapy].Critical appraisal of ranibizumab in the treatment of diabetic macular edema.
P2860
Q24193083-4E7BE994-07A4-4C8A-95ED-81957F31DD22Q24202071-5ED428D8-DA1D-4123-A2DC-26715AB07D7DQ24240165-E09FDEB1-EB0B-49E5-9715-1A7586E8D70FQ26775853-9AEF2F0D-8683-4046-B372-CD305D14FF1FQ26825365-6C33C3B5-E70E-47D7-8F4F-533B9D56849BQ26853239-68EA6C94-16E7-4B94-8FEE-0F1830D5F52DQ26995365-E760B87C-D85B-47CB-8CB7-F93DE39C7CB9Q27008325-DB4056FD-8F74-4E30-B2A6-07D0F303D7A8Q28084139-A8EA76D0-0BC2-4257-B6CC-F133037EE2CFQ28680651-99954403-A4A2-476D-83F7-5726FF81A82CQ30244247-926EBCFA-1FAE-409C-A8C0-1DD7C791AB50Q30415630-B48B0223-86BF-4CBB-8E04-FC83DDD31687Q30455644-007E574C-46FF-4A92-81CC-49C38293048EQ33542959-CBE5DF8D-650B-4ABD-816C-E6D0166B197EQ33583037-29DFD3D8-1BD8-46B7-B29A-ACC43A327B5BQ33606611-E303D708-E2FB-40F8-BF00-AD360306752BQ33636635-F1EDAC3E-2E40-4BA7-9E1A-2B4C01E7D34CQ33730079-684DF750-30C3-4405-AB6B-A9D65D6458F7Q33956443-9F4D037E-7C31-4E39-BB51-6D0CDE89813FQ33996047-A893BEBE-80B2-4C7E-8D4A-1B40EC807DC1Q34091784-2DE81270-0332-4195-A51E-20DB4028BAC0Q34119754-3ECA317C-CDA8-44C0-8FBC-1E03027832D7Q34185374-AA511C52-1F27-4E9B-B765-154491D1A8FBQ34185570-9BEBB4E6-5ED1-45E2-9DAD-D6D5B5E0EAC5Q34241921-7FDEF1D4-FD2F-4017-BEEA-6F965EDFD22EQ34244601-2DB70F9B-96E1-40FF-94C5-26B48354EEB2Q34249087-AFA96407-A0EC-4EFE-9A36-28A03A017C7DQ34267270-588CD0C3-F0F3-445E-9593-70789A86676EQ34378757-7B4990EF-FF81-41B2-AED0-35E288486106Q34385961-935CE249-EE92-48AB-A441-8051FE89E23DQ34413638-0CAB2554-3225-4A55-B5F7-FC8B46232E8EQ34528134-9389678E-FB67-4345-B8BB-94FCD76C771EQ34558187-19E35FB5-75BD-46E8-91EF-402F687FDF76Q34560674-376ECBA4-96A0-48F0-A8B8-8EF596C63581Q34606190-F771150D-2DC4-4A96-83B7-FBF75146EE59Q34675149-F2FBB9D1-B5CA-4EDD-82BB-B4DF661A4879Q34711043-391E56F8-1B1D-4ED6-80F0-BDB31E130AE4Q34752779-F44D695E-8877-494A-97E7-FA2AA0E6C81DQ34768919-08306B58-0BF1-4E51-A101-C537A46E2C11Q34803171-3F24F6DA-0525-42E2-A832-54AAF580F28D
P2860
Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema.
description
2009 nĆ® lÅ«n-bĆ»n
@nan
2009 Õ©ÕøÖÕ”ÕÆÕ”Õ¶Õ« Ō±ÕŗÖÕ«Õ¬Õ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕøÖÕ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ ÕµÖ
Õ¤ÕøÖÕ”Õ®
@hyw
2009 Õ©Õ¾Õ”ÕÆÕ”Õ¶Õ« Õ”ÕŗÖÕ«Õ¬Õ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕ¾Õ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ Õ°ÕøÕ¤Õ¾Õ”Õ®
@hy
2009幓ć®č«ę
@ja
2009幓č«ę
@yue
2009幓č«ę
@zh-hant
2009幓č«ę
@zh-hk
2009幓č«ę
@zh-mo
2009幓č«ę
@zh-tw
2009幓č®ŗę
@wuu
name
Randomized trial of intravitre ...... ion in diabetic macular edema.
@ast
Randomized trial of intravitre ...... ion in diabetic macular edema.
@en
type
label
Randomized trial of intravitre ...... ion in diabetic macular edema.
@ast
Randomized trial of intravitre ...... ion in diabetic macular edema.
@en
prefLabel
Randomized trial of intravitre ...... ion in diabetic macular edema.
@ast
Randomized trial of intravitre ...... ion in diabetic macular edema.
@en
P2093
P1433
P1476
Randomized trial of intravitre ...... ion in diabetic macular edema.
@en
P2093
Alireza Ramezani
Arash Obudi
Bijan Bijanzadeh
Gholam A Peyman
Hamid Ahmadieh
Masoud Salehipour
Masoud Soheilian
Mohammad H Dehghan
Mohsen Azarmina
Siamak Moradian
P304
P356
10.1016/J.OPHTHA.2009.01.011
P577
2009-04-19T00:00:00Z